肺癌全肺切除655例临床分析  

Pneumonectomy for Lung cancer：A Clinical Analysis of 655 Cases

作　　者：闫东杰[1] 窦学军[1] 白连启[1] 龚昌帆[1] 陈霄嘉[1] 李世业[1] 许绍发[1] 杨声 

机构地区：[1]北京胸科医院胸外科

出　　处：《结核病与胸部肿瘤》2007年第3期203-206,共4页Tuberculosis and Thoracic Tumor

摘　　要：目的探讨全肺切除术在中晚期肺癌治疗中的作用。方法对1994年10月至2003年11月行全肺切除术的655例肺癌病例进行回顾性分析。结果全组1、3、5年生存率为88．o％、50．9％、24．1％。按照TNM分期5年生存率：Ⅰa期37．0％，Ⅰb期40．6％，Ⅱa期0％，Ⅱb期37．9％，Ⅲa期19．3％，Ⅲb期7．O％，Ⅳ期17．7％。不同病理类型5年生存率：非小细胞癌24．5％，小细胞癌22．0％。术后死亡率和并发症率分别为2．4％和10．4％。结论全肺切除术有可接受的术后死亡率和并发症率。在严格掌握手术适应症的基础上，术中操作熟练规范。重视围手术期的观察和处理，全肺切除术对于治疗中、晚期肺癌仍不失为一种有效的方法。Objective To investigate the role of pneumoneetomy for the treatment of patients with lung cancer. Methods We retrospectively analyzed 655 consecutive patients with lung cancer treated with pneumonectomy between October 1994 and November 2003. Results The 1,3,5-year survival rate were 88.02%,50.09% and 24.1% respectively, in these patients. The 5-year survival rate for different pTNM staging were as follows： NSCLC 24.5% and SCLC 22.0%. The postoperative mortality was 2.4% and complication incidence was 10.4%. Conclusion On the basis of strict operation indication and practiced thoracic surgeon, pneumonectomy is a effective way in treating with middle and advanced stage lung cancer and shows acceptable postoperative morbidity and mortality.

关 键 词：肺肿瘤 全肺切除术 

分 类 号：R655.3[医药卫生—外科学]